SCHEMBL25478232

SCHEMBL25478232

COCCOc1cc2ncnc(Nc3ccc(Cl)c(Cl)c3F)c2cc1O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 13/20 0.65
FLT1 P17948 7/20 0.62
FGFR1 P11362 2/20 0.62
FLT4 P35916 2/20 0.62
FGFR2 P21802 1/20 0.62
FGFR4 P22455 1/20 0.62
FGFR3 P22607 1/20 0.62
EGFR P00533 7/20 0.59
ERBB2 P04626 6/20 0.57
EPHA2 P29317 6/20 0.56
EPHB4 P54760 5/20 0.56
RET P07949 5/20 0.56
GAK O14976 1/20 0.56
EPHB6 O15197 1/20 0.56
RIPK2 O43353 1/20 0.56
STK10 O94804 1/20 0.56
MAP4K4 O95819 1/20 0.56
ABL1 P00519 1/20 0.56
LCK P06239 1/20 0.56
YES1 P07947 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25476984 0.90 EGFR (0.57) KDRFLT1FGFR1FLT4FGFR2
SCHEMBL30459542 0.89 EGFR (0.70) KDRFLT1FGFR1FLT4EGFR
SCHEMBL14843536 0.89 EGFR (0.70) KDRFLT1FGFR1FLT4EGFR
SCHEMBL29453257 0.89 EGFR (0.70) KDRFLT1FGFR1FLT4EGFR
SCHEMBL25488948 0.89 EGFR (0.54) KDRFLT1FGFR1FLT4FGFR2
Hydrochloric Acid SCHEMBL28257165 0.88 EGFR (0.69) KDRFLT1FGFR1FLT4EGFR
SCHEMBL6018368 0.85 EGFR (0.68) KDRFLT1FGFR1FLT4EGFR
SCHEMBL18012884 0.85 EGFR (0.53) KDRFLT1FGFR1FLT4FGFR2
SCHEMBL16212500 0.84 KDR (0.57) KDRFLT1FGFR1FLT4FGFR2
SCHEMBL22631259 0.84 EGFR (0.58) KDRFLT1EGFRERBB2EPHA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3733663-B1 1-[6-[[4-(PHENYLAMINO)-6-QUINAZOLINYL]OXY]-3-AZABICYCLO[3.1.1]HEPT-3-YL]-2-PROPEN-1-ONE DERIVATIVES AND RELATED COMPOUNDS AS IRREVERSIBLE INHIBITORS OF PAN-HER TYROSINE KINASE FOR THE TREATMENT OF CANCER CHENGDU JINRUI FOUND BIOTECH CO LTD (CN) 2023-05-17 EP disclosed